These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 34966691)
1. Tumor Immune Microenvironment Related Gene-Based Model to Predict Prognosis and Response to Compounds in Ovarian Cancer. Yang J; Hong S; Zhang X; Liu J; Wang Y; Wang Z; Gao L; Hong L Front Oncol; 2021; 11():807410. PubMed ID: 34966691 [TBL] [Abstract][Full Text] [Related]
2. The levels of immunosuppressive checkpoint protein PD-L1 and tumor-infiltrating lymphocytes were integrated to reveal the glioma tumor microenvironment. Zhang W; Liu L; Liu X; Han C; Li Q Environ Toxicol; 2024 Feb; 39(2):815-829. PubMed ID: 37792606 [TBL] [Abstract][Full Text] [Related]
3. A novel tumor mutational burden-based risk model predicts prognosis and correlates with immune infiltration in ovarian cancer. Wang H; Liu J; Yang J; Wang Z; Zhang Z; Peng J; Wang Y; Hong L Front Immunol; 2022; 13():943389. PubMed ID: 36003381 [TBL] [Abstract][Full Text] [Related]
4. Development and verification of a 7-lncRNA prognostic model based on tumor immunity for patients with ovarian cancer. Feng J; Yu Y; Yin W; Qian S J Ovarian Res; 2023 Feb; 16(1):31. PubMed ID: 36739404 [TBL] [Abstract][Full Text] [Related]
5. A signature based on anoikis-related genes for the evaluation of prognosis, immunoinfiltration, mutation, and therapeutic response in ovarian cancer. Duan Y; Xu X Front Endocrinol (Lausanne); 2023; 14():1193622. PubMed ID: 37383389 [TBL] [Abstract][Full Text] [Related]
6. Identifying immune-related prognostic biomarkers in osteosarcoma: Development and validation of the tumor immune microenvironment risk model based on analysis of TCGA. Zhang X; Fan Y; Shen Z; Chen Z; You W Environ Toxicol; 2024 Mar; ():. PubMed ID: 38462917 [TBL] [Abstract][Full Text] [Related]
7. Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Endometrial Carcinoma to Immunotherapy and Chemotherapy. Liu J; Wang Y; Mei J; Nie S; Zhang Y Front Cell Dev Biol; 2021; 9():671736. PubMed ID: 34368124 [TBL] [Abstract][Full Text] [Related]
8. A signature of tumor immune microenvironment genes associated with the prognosis of non‑small cell lung cancer. Li J; Li X; Zhang C; Zhang C; Wang H Oncol Rep; 2020 Mar; 43(3):795-806. PubMed ID: 32020214 [TBL] [Abstract][Full Text] [Related]
9. Identification of an Autophagy-Related Signature for Prognosis and Immunotherapy Response Prediction in Ovarian Cancer. Ding J; Wang C; Sun Y; Guo J; Liu S; Cheng Z Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830707 [TBL] [Abstract][Full Text] [Related]
10. Identification of CDK2-Related Immune Forecast Model and ceRNA in Lung Adenocarcinoma, a Pan-Cancer Analysis. Liu TT; Li R; Huo C; Li JP; Yao J; Ji XL; Qu YQ Front Cell Dev Biol; 2021; 9():682002. PubMed ID: 34409029 [TBL] [Abstract][Full Text] [Related]
11. Identification of STEAP3-based molecular subtype and risk model in ovarian cancer. Zhao Z; Sun C; Hou J; Yu P; Wei Y; Bai R; Yang P J Ovarian Res; 2023 Jun; 16(1):126. PubMed ID: 37386521 [TBL] [Abstract][Full Text] [Related]
12. Immune and Stroma Related Genes in Breast Cancer: A Comprehensive Analysis of Tumor Microenvironment Based on the Cancer Genome Atlas (TCGA) Database. Xu M; Li Y; Li W; Zhao Q; Zhang Q; Le K; Huang Z; Yi P Front Med (Lausanne); 2020; 7():64. PubMed ID: 32195260 [No Abstract] [Full Text] [Related]
13. A signature based on glycosyltransferase genes provides a promising tool for the prediction of prognosis and immunotherapy responsiveness in ovarian cancer. Xu X; Wu Y; Jia G; Zhu Q; Li D; Xie K J Ovarian Res; 2023 Jan; 16(1):5. PubMed ID: 36611197 [TBL] [Abstract][Full Text] [Related]
14. Development and validation of a novel lipid metabolism-related gene prognostic signature and candidate drugs for patients with bladder cancer. Zhu K; Xiaoqiang L; Deng W; Wang G; Fu B Lipids Health Dis; 2021 Oct; 20(1):146. PubMed ID: 34706720 [TBL] [Abstract][Full Text] [Related]
15. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer. Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366 [TBL] [Abstract][Full Text] [Related]
16. Identification and Validation of Angiogenesis-Related Gene Expression for Predicting Prognosis in Patients With Ovarian Cancer. Wang Y; Li BX; Li X Front Oncol; 2021; 11():783666. PubMed ID: 35047401 [TBL] [Abstract][Full Text] [Related]
17. A Prognostic Model Using Immune-Related Genes for Colorectal Cancer. Feng W; Zhang Y; Liu W; Wang X; Lei T; Yuan Y; Chen Z; Song W Front Cell Dev Biol; 2022; 10():813043. PubMed ID: 35252182 [TBL] [Abstract][Full Text] [Related]
18. Four differentially expressed genes can predict prognosis and microenvironment immune infiltration in lung cancer: a study based on data from the GEO. Wen S; Peng W; Chen Y; Du X; Xia J; Shen B; Zhou G BMC Cancer; 2022 Feb; 22(1):193. PubMed ID: 35184748 [TBL] [Abstract][Full Text] [Related]
19. Identification of Stemness Characteristics Associated With the Immune Microenvironment and Prognosis in Gastric Cancer. Mao D; Zhou Z; Song S; Li D; He Y; Wei Z; Zhang C Front Oncol; 2021; 11():626961. PubMed ID: 33747944 [TBL] [Abstract][Full Text] [Related]
20. A combined hypoxia and immune gene signature for predicting survival and risk stratification in triple-negative breast cancer. Yang X; Weng X; Yang Y; Zhang M; Xiu Y; Peng W; Liao X; Xu M; Sun Y; Liu X Aging (Albany NY); 2021 Aug; 13(15):19486-19509. PubMed ID: 34341184 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]